China · Delayed Price · Currency is CNY Zhende Medical Statistics
Total Valuation
Zhende Medical has a market cap or net worth of CNY 18.85 billion. The enterprise value is 19.46 billion.
| Market Cap | 18.85B |
| Enterprise Value | 19.46B |
Important Dates
The next estimated earnings date is Friday, April 24, 2026.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | Jun 11, 2025 |
Share Statistics
Zhende Medical has 265.71 million shares outstanding. The number of shares has decreased by -1.31% in one year.
| Current Share Class | 265.71M |
| Shares Outstanding | 265.71M |
| Shares Change (YoY) | -1.31% |
| Shares Change (QoQ) | +2.68% |
| Owned by Insiders (%) | 9.99% |
| Owned by Institutions (%) | 7.09% |
| Float | 105.51M |
Valuation Ratios
The trailing PE ratio is 67.08 and the forward PE ratio is 48.26.
| PE Ratio | 67.08 |
| Forward PE | 48.26 |
| PS Ratio | 4.36 |
| PB Ratio | 3.15 |
| P/TBV Ratio | 4.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 33.40 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.82, with an EV/FCF ratio of -150.10.
| EV / Earnings | 69.27 |
| EV / Sales | 4.50 |
| EV / EBITDA | 34.82 |
| EV / EBIT | 60.53 |
| EV / FCF | -150.10 |
Financial Position
The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.24.
| Current Ratio | 1.67 |
| Quick Ratio | 1.11 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 2.52 |
| Debt / FCF | -10.87 |
| Interest Coverage | 10.77 |
Financial Efficiency
Return on equity (ROE) is 4.91% and return on invested capital (ROIC) is 4.45%.
| Return on Equity (ROE) | 4.91% |
| Return on Assets (ROA) | 2.47% |
| Return on Invested Capital (ROIC) | 4.45% |
| Return on Capital Employed (ROCE) | 4.83% |
| Weighted Average Cost of Capital (WACC) | 8.75% |
| Revenue Per Employee | 553,703 |
| Profits Per Employee | 35,980 |
| Employee Count | 7,807 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 3.69 |
Taxes
In the past 12 months, Zhende Medical has paid 53.19 million in taxes.
| Income Tax | 53.19M |
| Effective Tax Rate | 15.49% |
Stock Price Statistics
The stock price has increased by +229.19% in the last 52 weeks. The beta is 0.91, so Zhende Medical's price volatility has been similar to the market average.
| Beta (5Y) | 0.91 |
| 52-Week Price Change | +229.19% |
| 50-Day Moving Average | 72.90 |
| 200-Day Moving Average | 42.91 |
| Relative Strength Index (RSI) | 50.91 |
| Average Volume (20 Days) | 2,959,462 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Zhende Medical had revenue of CNY 4.32 billion and earned 280.90 million in profits. Earnings per share was 1.06.
| Revenue | 4.32B |
| Gross Profit | 1.41B |
| Operating Income | 321.47M |
| Pretax Income | 343.47M |
| Net Income | 280.90M |
| EBITDA | 554.55M |
| EBIT | 321.47M |
| Earnings Per Share (EPS) | 1.06 |
Balance Sheet
The company has 1.08 billion in cash and 1.41 billion in debt, with a net cash position of -326.49 million or -1.23 per share.
| Cash & Cash Equivalents | 1.08B |
| Total Debt | 1.41B |
| Net Cash | -326.49M |
| Net Cash Per Share | -1.23 |
| Equity (Book Value) | 5.99B |
| Book Value Per Share | 21.41 |
| Working Capital | 1.17B |
Cash Flow
In the last 12 months, operating cash flow was 564.26 million and capital expenditures -693.90 million, giving a free cash flow of -129.63 million.
| Operating Cash Flow | 564.26M |
| Capital Expenditures | -693.90M |
| Free Cash Flow | -129.63M |
| FCF Per Share | -0.49 |
Margins
Gross margin is 32.51%, with operating and profit margins of 7.44% and 6.50%.
| Gross Margin | 32.51% |
| Operating Margin | 7.44% |
| Pretax Margin | 7.95% |
| Profit Margin | 6.50% |
| EBITDA Margin | 12.83% |
| EBIT Margin | 7.44% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.65, which amounts to a dividend yield of 0.92%.
| Dividend Per Share | 0.65 |
| Dividend Yield | 0.92% |
| Dividend Growth (YoY) | -48.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 70.61% |
| Buyback Yield | 1.31% |
| Shareholder Yield | 2.25% |
| Earnings Yield | 1.49% |
| FCF Yield | -0.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 8, 2020. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 8, 2020 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
Zhende Medical has an Altman Z-Score of 2.93 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.93 |
| Piotroski F-Score | 7 |